[HTML][HTML] Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
LH Schrijver, AC Antoniou, H Olsson, TM Mooij… - American Journal of …, 2021 - Elsevier
Background Ovarian cancer risk in BRCA1 and BRCA2 mutation carriers has been shown to
decrease with longer duration of oral contraceptive use. Although the effects of using oral …
decrease with longer duration of oral contraceptive use. Although the effects of using oral …
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
LH Schrijver, AC Antoniou, H Olsson… - American Journal of …, 2021 - europepmc.org
Background Ovarian cancer risk in BRCA1 and BRCA2 mutation carriers has been shown to
decrease with longer duration of oral contraceptive use. Although the effects of using oral …
decrease with longer duration of oral contraceptive use. Although the effects of using oral …
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
L Schrijver, A Antoniou, H Olsson, T Mooij… - American Journal of …, 2021 - hal.uvsq.fr
Background: Ovarian cancer risk in BRCA1 and BRCA2 mutation carriers has been shown
to decrease with longer duration of oral contraceptive use. Although the effects of using oral …
to decrease with longer duration of oral contraceptive use. Although the effects of using oral …
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
LH Schrijver, AC Antoniou, H Olsson… - Am. J. Obstet …, 2021 - kups.ub.uni-koeln.de
Obstetrical complications, often referred to as the great obstetrical syndromes, are among
the most common global causes of mortality and morbidity in young women and their infants …
the most common global causes of mortality and morbidity in young women and their infants …
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
L Schrijver, A Antoniou, H Olsson… - American Journal of …, 2021 - hal.insa-toulouse.fr
Background: Ovarian cancer risk in BRCA1 and BRCA2 mutation carriers has been shown
to decrease with longer duration of oral contraceptive use. Although the effects of using oral …
to decrease with longer duration of oral contraceptive use. Although the effects of using oral …
[PDF][PDF] Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
LH Schrijver, AC Antoniou, H Olsson, TM Mooij… - 2021 - repository.ubn.ru.nl
BACKGROUND: Ovarian cancer risk in BRCA1 and BRCA2 mutation carriers has been
shown to decrease with longer duration of oral contraceptive use. Although the effects of …
shown to decrease with longer duration of oral contraceptive use. Although the effects of …
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
L Schrijver, A Antoniou, H Olsson, T Mooij… - American Journal of …, 2021 - hal.science
Background: Ovarian cancer risk in BRCA1 and BRCA2 mutation carriers has been shown
to decrease with longer duration of oral contraceptive use. Although the effects of using oral …
to decrease with longer duration of oral contraceptive use. Although the effects of using oral …
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
LH Schrijver, AC Antoniou, H Olsson… - American Journal of …, 2021 - research.rug.nl
Background Ovarian cancer risk in BRCA1 and BRCA2 mutation carriers has been shown to
decrease with longer duration of oral contraceptive use. Although the effects of using oral …
decrease with longer duration of oral contraceptive use. Although the effects of using oral …
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
LH Schrijver, AC Antoniou, H Olsson… - American Journal of …, 2021 - research.regionh.dk
BACKGROUND: Ovarian cancer risk in BRCA1 and BRCA2 mutation carriers has been
shown to decrease with longer duration of oral contraceptive use. Although the effects of …
shown to decrease with longer duration of oral contraceptive use. Although the effects of …
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
L Schrijver, A Antoniou, H Olsson, T Mooij… - American Journal of …, 2021 - inria.hal.science
Background: Ovarian cancer risk in BRCA1 and BRCA2 mutation carriers has been shown
to decrease with longer duration of oral contraceptive use. Although the effects of using oral …
to decrease with longer duration of oral contraceptive use. Although the effects of using oral …